DIABETES

Effectiveness of high‐intensity interval training combined with resistance training versus continuous moderate‐intensity training combined with resistance training in patients with type 2 diabetes: A one‐year randomized controlled trial

β-Cell–Derived Angiopoietin-1 Regulates Insulin Secretion and Glucose Homeostasis by Stabilizing the Islet Microenvironment

Microbiota-Produced N-Formyl Peptide fMLF Promotes Obesity-Induced Glucose Intolerance

Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial

Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes

FDA guidance on cardiovascular risk of antidiabetic therapies: One decade later

174-LB: Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications

389-P: Comparison of Hormonal Response to a Mixed-Meal Challenge in Individuals with Hypoglycemia after Sleeve Gastrectomy vs. Gastric Bypass

Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial

Persistent whole day meal effects of three dipeptidyl peptidase‐4 inhibitors on glycaemia and hormonal responses in metformin‐treated type 2 diabetes

1342-P: Development of Type 2 Diabetes (T2D) in Obese Adolescent Girls with Polycystic Ovary Syndrome (PCOS)

News and Views July 2019

1186-P: Lean Women with Polycystic Ovary Syndrome and Insulin Resistance Have Normal Incretin Effect, which Is Unaffected by Metformin Therapy

479-P: Combination of Trans-resveratrol and Hesperetin Corrects Unscheduled Increased Glucose Metabolism Driving Dysfunction of Human Periodontal Ligament Fibroblasts in Hyperglycemia In Vitro

435-P: Elevated One-Hour Post-Challenge Glucose Levels Associated with Increased Arterial Stiffness

935-P: Identification of Characteristic Daily Glucose Excursions Associated with Triopathy in Adults with Type 1 Diabetes

1397-P: A Pregnancy Lifestyle Intervention Improves Metabolic Profile of Women and Infants by Reducing Gestational Weight Gain (GWG): The GLOW Randomized Controlled Trial

2114-P: Use of Visceral Fat Area Measurement for Evaluating Obesity in Elderly Patients with Type 2 Diabetes

242-OR: Do GLP-1RA and SGLT2i Reduce Cardiovascular Mortality in African-American Patients with Type 2 Diabetes? A Meta-analysis

189-LB: Maternal Pharmacological Activation of PPAR-gamma or PPAR-alpha Differentially Affects Adiposity and Energy Metabolism in the Offspring of Rats Born to Mothers Subjected to Caloric Restriction during Pregnancy

2388-PUB: App-Based Diabetes Management Plan: An Analogy between Diabetes Awareness and Plan Adoption

1875-P: Liver-Specific p38 MAPK Stimulates Hepatic Fat Accumulation and Reduces Insulin Sensitivity In Vivo

1205-P: Baseline Lactate Level Is a Useful Predictor for Weight Loss after Long-Term SGLT2 Inhibitor Treatment

News and Views May 2019

2398-PUB: The Interplay of Type 1 Diabetes and Weight: A Qualitative Study of Thematic Progression with Age

1275-P: Cost Effectiveness of Using DPP-4i and SGLT2i Combination Therapy vs. Switching to GLP-1 Therapy for the Management of Type 2 Diabetes

2237-PUB: Validation of the Simple Diagnostic Criteria in Japan

2070-P: Role of Education Attainment in Obesity: A Two-Sample Mendelian Randomization Study

815-P: Eating Behaviors, Personality Traits, and Diabetes Fatalism: Predictors of HbA1c in Type 2 Diabetes

331-OR: Glycemic Index and Postprandial Blood Glucose Excursions, Insulin Requirements, and Hunger in T1D

1119-P: Efficacy and Safety of Sitagliptin (SITA) Compared with Dapagliflozin (DAPA) in People ≥65 Years Old with T2D

1108-P: The Total Basal Dose (TBD) Is about 35% of Total Daily Dose (TDD) and TBD/Weight Is about 0.23U/kg: 144 Subjects Titrated by Continuous Glucose Monitoring (CGM) while under Dietary Control

1772-P: Insulin Granule Biogenesis at the Golgi Requires a Metabolically-Regulated, Non-centrosomal Subpopulation of Microtubules

2263-PUB: Implementation of a Diabetes Self-Management Education (DSME) Program as Part of Discharge Counseling at a County Hospital

1294-P: Detection and Intervention of Prediabetes in a Large Urban Health System: Systematic Failure or Looming Opportunity?

152-LB: Sodium-Glucose Cotransporter Inhibitor Impairs Adhesion of Cancer Cells by Increasing Shedding and Dephosphorylation of Discoid Domain Receptor

197-LB: Factors Associated with Screening for Diabetes in Low-Income Women after a Pregnancy with Gestational Diabetes

97-LB: Point-of-Care HbA1c Testing in Redesign of Diabetes Management Program Lowered Costs and Improved Outcomes

2354-PUB: Estimating Improvement of TGF Mechanism from Changes of Urinary Glucose and Sodium Excretion by SGLT2 Inhibitors

115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes

1548-P: High Prevalence of Glaucoma and Cataract with Uncommon Diabetic Retinopathy in Haitian Youth with Diabetes

159-OR: Changes in Dairy Product Consumption and Risk of Type 2 Diabetes among U.S. Men and Women

Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors

738-P: Meta’omic Analysis of Elite Athletes Identifies a Performance-Enhancing Microbe that Functions via Lactate Metabolism

1986-P: Hippocampal Overexpression of Triggering Receptor Expressed on Myeloid Cell 2 (TREM2) Ameliorates High-Fat Diet-Induced Neurocognitive Impairment via Modulating Microglial M1/M2 Polarization

1647-P: High Serum YKL-40 Concentration Is Associated with One-Hour Post-Load Hyperglycemia

1728-P: Inhibition of PKC-Theta in Prediabetic NOD Mice Prevents Diabetes Onset and Increases Regulatory CD4 T Cells in a Subset of Animals